NCT00620256 arm group 4490f524530b60279ad3161904e87ff7 [clinicaltrials_resource:NCT00620256/arm-group/4490f524530b60279ad3161904e87ff7]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00620256 arm group 4490f524530b60279ad3161904e87ff7 [clinicaltrials_resource:NCT00620256/arm-group/4490f524530b60279ad3161904e87ff7]
Bio2RDF identifier
NCT00620256/arm-group/4490f524530b60279ad3161904e87ff7
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 90f524530b60279ad3161904e87ff7
description [clinicaltrials_vocabulary:description]
AL-37807 ophthalmic suspension ...... eye(s) at 8 PM, for four weeks
identifier
clinicaltrials_resource:NCT00620256/arm-group/4490f524530b60279ad3161904e87ff7
title
NCT00620256 arm group 4490f524530b60279ad3161904e87ff7
@en
type
label
NCT00620256 arm group 4490f524 ...... 0f524530b60279ad3161904e87ff7]
@en